Polo-like kinase is a cell cycle-regulated kinase activated during mitosis - PubMed (original) (raw)
. 1995 Sep 8;270(36):21086-91.
doi: 10.1074/jbc.270.36.21086.
Affiliations
- PMID: 7673138
- DOI: 10.1074/jbc.270.36.21086
Free article
Polo-like kinase is a cell cycle-regulated kinase activated during mitosis
R Hamanaka et al. J Biol Chem. 1995.
Free article
Abstract
Previously, we demonstrated that expression of polo-like kinase (PLK) is required for cellular DNA synthesis and that overexpression of PLK is sufficient to induce DNA synthesis. We now report that the endogenous levels of PLK, its phosphorylation status, and protein kinase activity are tightly regulated during cell cycle progression. PLK protein is low in G1, accumulates during S and G2M, and is rapidly reduced after mitosis. During mitosis, PLK is phosphorylated on serine, and its serine threonine kinase function is activated at a time close to that of p34cdc2. The phosphorylated form of PLK migrates with reduced mobility on SDS-polyacrylamide gel electrophoresis, and dephosphorylation by purified protein phosphatase 2A converts it to the more rapidly migrating form and reduces the total amount of PLK kinase activity. Purified p34cdc2-cyclin B complex can phosphorylate PLK protein in vitro but causes little increase in PLK kinase activity.
Similar articles
- The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase.
Roshak AK, Capper EA, Imburgia C, Fornwald J, Scott G, Marshall LA. Roshak AK, et al. Cell Signal. 2000 Jun;12(6):405-11. doi: 10.1016/s0898-6568(00)00080-2. Cell Signal. 2000. PMID: 11202906 - Plk is an M-phase-specific protein kinase and interacts with a kinesin-like protein, CHO1/MKLP-1.
Lee KS, Yuan YL, Kuriyama R, Erikson RL. Lee KS, et al. Mol Cell Biol. 1995 Dec;15(12):7143-51. doi: 10.1128/MCB.15.12.7143. Mol Cell Biol. 1995. PMID: 8524282 Free PMC article. - The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk.
Golan A, Yudkovsky Y, Hershko A. Golan A, et al. J Biol Chem. 2002 May 3;277(18):15552-7. doi: 10.1074/jbc.M111476200. Epub 2002 Feb 21. J Biol Chem. 2002. PMID: 11859075 - [The characterization of human cdc2 kinase and CDK2].
Yasuda H, Kamijo M, Ohba Y. Yasuda H, et al. Yakugaku Zasshi. 1993 Dec;113(12):829-46. doi: 10.1248/yakushi1947.113.12_829. Yakugaku Zasshi. 1993. PMID: 8301538 Review. Japanese. - Dynamic changes in nuclear architecture during mitosis: on the role of protein phosphorylation in spindle assembly and chromosome segregation.
Nigg EA, Blangy A, Lane HA. Nigg EA, et al. Exp Cell Res. 1996 Dec 15;229(2):174-80. doi: 10.1006/excr.1996.0356. Exp Cell Res. 1996. PMID: 8986594 Review.
Cited by
- Targeting the cell cycle in esophageal adenocarcinoma: an adjunct to anticancer treatment.
Dibb M, Ang YS. Dibb M, et al. World J Gastroenterol. 2011 Apr 28;17(16):2063-9. doi: 10.3748/wjg.v17.i16.2063. World J Gastroenterol. 2011. PMID: 21547123 Free PMC article. Review. - The polo-like kinase Plx1 is required for M phase exit and destruction of mitotic regulators in Xenopus egg extracts.
Descombes P, Nigg EA. Descombes P, et al. EMBO J. 1998 Mar 2;17(5):1328-35. doi: 10.1093/emboj/17.5.1328. EMBO J. 1998. PMID: 9482730 Free PMC article. - Cell cycle control, checkpoint mechanisms, and genotoxic stress.
Shackelford RE, Kaufmann WK, Paules RS. Shackelford RE, et al. Environ Health Perspect. 1999 Feb;107 Suppl 1(Suppl 1):5-24. doi: 10.1289/ehp.99107s15. Environ Health Perspect. 1999. PMID: 10229703 Free PMC article. Review. - Inhibition of DNMT3B and PI3K/AKT/mTOR and ERK Pathways as a Novel Mechanism of Volasertib on Hypomethylating Agent-Resistant Cells.
Choi EJ, Koo BK, Hur EH, Moon JH, Kim JY, Park HS, Choi Y, Lee KH, Lee JH, Choi EK, Lee JH. Choi EJ, et al. Biomol Ther (Seoul). 2023 May 1;31(3):319-329. doi: 10.4062/biomolther.2022.117. Epub 2022 Nov 16. Biomol Ther (Seoul). 2023. PMID: 36382510 Free PMC article. - The Polo kinase Cdc5 is regulated at multiple levels in the adaptation response to telomere dysfunction.
Coutelier H, Ilioaia O, Le Peillet J, Hamon M, D'Amours D, Teixeira MT, Xu Z. Coutelier H, et al. Genetics. 2023 Jan 12;223(1):iyac171. doi: 10.1093/genetics/iyac171. Genetics. 2023. PMID: 36342193 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous